For example, among the core AD blood biomarkers, Aβ40 and Aβ42 tend to be most prone to degradation and should therefore be measured first, if possible, followed by t-tau, p-tau, BD-tau and finally GFAP and NfL. Here, NEFL is linked to Alzheimer disease.